Dindin, Cerilo C.

HRN: 25-63-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/02/2026
01/09/2026
IV
2.25g
Q8
Cap
Checking Final Appropriateness 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: